Abstract
Adult onset Still’s disease (AOSD) is a well-recognized clinical disorder characterized by involvement of various organs, including liver. However, acute hepatitis or hepatic failure is extremely rare, and most of the reported cases occurred during treatment with hepatotoxic drugs. Anakinra is an interleukin-1 receptor antagonist (IL-1Ra). Experimental and clinical data support a central role for IL-1Ra in fulminant hepatic failure. We report the case of a patient with AOSD complicated with acute hepatitis during treatment with corticosteroids, which was dramatically improved with anakinra.
References
Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheum 19:424–430
Pouchot J, Sampalis JS, Beaudet F et al (1991) Adult Still’s disease: manifestations, disease course and outcome in 62 patients. Med 70(2):118–136
McFarlane M, Harth M, Wall WJ (1997) Liver transplantation in adult Still’s disease. J Rheum 24:2038–2041
Dino O, Provenzano G, Giannuoli G et al (1996) Fulminant hepatic failure in adult onset Still’s disease. J Rheum 23:784–785
Reginato AJ, Schumacher RH, Baker DG et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39–57
Ott SJ, Baron A, Berghaus T et al (2003) Liver failure in adult Still’s disease during corticosteroid treatment. Eur J Gastroenterol Hepatol 15:87–90
Godhino FM, Santos MJ, Canas da Silva J (2005) Refractory adult onset Still’s disease successfully treated with anakinra. Ann Rheum Dis 64:647–648
Fitzgerald AA, LeClercq SA, Yan A et al (2005) Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum 52(6):1794–1803
Yamanaka J, Saito S, Kuroda N et al (2003) Successful living related liver transplantation for adult Still’s disease. J Gastroenterol Hepatol 18:1109–1111
Bywaters EGL (1971) Still’s disease in the adult. Ann Rheum Dis 30:121–133
Larson EB (1984) Adult Still’s disease: Evolution of a clinical syndrome and diagnosis, treatment and follow up of 17 patients. Medicine (Baltimore) 63:82–91
Ogata A, Kitano M, Yamanaka J et al (2003) Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still’s disease. J Rheum 30:1093–1096
Michel M, Duvoux C, Hezode C et al (2003) Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still’s disease. J Rheum 30:1624–1625
Shinoda M, Tilles AW, Wakabayashi G et al (2006) Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist. Tissue Eng 12(5):1313–1323
Sekiyama KD, Yoshiba M, Thomson AW (1994) Circulating proinflammatory cytokines (IL-1β, TNF-α and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98:71–77
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mylona, E., Golfinopoulou, S., Samarkos, M. et al. Acute hepatitis in adult Still’s disease during corticosteroid treatment successfully treated with anakinra. Clin Rheumatol 27, 659–661 (2008). https://doi.org/10.1007/s10067-007-0791-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0791-y